These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21293088)

  • 21. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA; Hilleman DE
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
    Oparil S; Weber M
    Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
    Kushiro T; Itakura H; Abo Y; Gotou H; Terao S; Keefe DL
    Hypertens Res; 2009 Mar; 32(3):169-75. PubMed ID: 19262478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valsartan plus hydrochlorothiazide for first-line therapy in hypertension.
    Lacourcière Y; Poirier L; Samuel R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1491-501. PubMed ID: 19954310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are fixed-dose combination antihypertensives suitable as first-line therapy?
    Kjeldsen SE; Messerli FH; Chiang CE; Meredith PA; Liu L
    Curr Med Res Opin; 2012 Oct; 28(10):1685-97. PubMed ID: 22978777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing cardiovascular events and end-organ damage in patients with hypertension: new considerations.
    Harmon L; Chilton RJ; Spellman C
    Postgrad Med; 2011 Mar; 123(2):7-17. PubMed ID: 21474888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
    Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T
    Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do compliance, convenience, and tolerability affect blood pressure goal rates?
    Erdine S
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):295-302. PubMed ID: 22920049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achieving Goal Blood Pressure.
    Laurent S
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S5-9. PubMed ID: 26002423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance with the treatment of hypertension: the potential of combination therapy.
    Erdine S
    J Clin Hypertens (Greenwich); 2010 Jan; 12(1):40-6. PubMed ID: 20047629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming barriers to effective blood pressure control in patients with hypertension.
    Düsing R
    Curr Med Res Opin; 2006 Aug; 22(8):1545-53. PubMed ID: 16870079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.